Inbound queue.

Phase 2 cGMP supply RFP, BX-3142 (50 kg)

Hi team, please find attached the full RFP package for BX-3142, our 31-residue GLP-1 analog peptide entering Phase 2. We need 50 kg of cGMP API for clinical supply, 9-month timeline, US/EU/JP filing strategy.

Phase 1 enabling, NV-2207 small-molecule kinase inhibitor

Reaching out about NV-2207, our oral small-molecule SYK kinase inhibitor for autoimmune indications. We need 15 kg cGMP API for tox + Phase 1 clinical, IND-ready by end of 2026.

ADC payload manufacturing, AT-118

We need a CDMO partner for AT-118, the cytotoxic small-molecule payload for our ADC program. 8 kg cGMP for Phase 1 supply. OEB-4 handling required throughout.